Merck says some patents for its top-selling cancer drug, Keytruda, may be extended through 2029.

Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...

Nvidia CEO Jensen Huang and Dassault Systemes CEO Pascal Daloz join 'Mad Money' host Jim Cramer to talk the details of the newly announced long-term partnership between the two companies.

Merck Foundation Chief Executive Officer (CEO) together with African First Ladies mark ‘World Cancer Day 2026’ by building ...

In its 2025 full year and fourth-quarter earnings call, Merck executives touted the merits of recent deals and what CEO ...

By Michael Erman and Mariam Sunny Feb 3 (Reuters) - Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates, saying the imminent loss of exclusivity on diabetes drug Januvia ...

And Zimbabwe First Lady Discussed The Impact Of Their Programs - Train Healthcare Providers, Support Infertile Women & Girl Education. Merck Foundation ( ) CEO, Dr. Rasha Kelej met H.E. Amai Dr.

On January 27, Cantor Fitzgerald boosted its price target on Merck & Co., Inc. (NYSE:MRK) to $116 from $83 but kept its ...

Merck reported revenue for the fourth quarter was $16.4 billion, an increase of 5% over the fourth quarter of 2024. For the ...